Comparative effectiveness of dual antiplatelet therapy versus monotherapy in patients with ischemic stroke

References

1. 1.↵
   1. Tadi Prasanna FL

   . Acute Stroke. [Updated 2023 Feb 28]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan [Internet]. 2023 [cited 2023 May 26]. p. 88–100.
2. 2.↵
   1. Muhammad AT,
   2. Aljohani MM

   . Stroke In KSA ; Epidemiology And Clinical Delineation. Majmaah J Heal Sci 2021; 9: 109–120.

   OpenUrl
3. 3.↵
   1. Franziska H,
   2. Fred R

   . Management of Acute Ischemic Stroke. Concise Defin Rev 2020; 48: 1654–1663.

   OpenUrl
4. 4.↵
   1. Edward CJ

   . Ischemic stroke [Internet]. Medical Crossfire. 2022 [cited 2023 May 26]. Available from: https://emedicine.medscape.com/article/1916852-overview
5. 5.↵
   1. Yiping C,
   2. Neil W,
   3. Yu G,
   4. Iain T,
   5. Christiana K,
   6. Ling Y, et al.

   Mortality and recurrent vascular events after first incident stroke: a 9-year community-based study of 0·5 million Chinese adults. Lancet Glob Heal 2020; 8: e580–e590.

   OpenUrl
6. 6.↵
   1. Stahmeyer JT,
   2. Stubenrauch S,
   3. Geyer S,
   4. Weissenborn K,
   5. Eberhard S

   . The Frequency and Timing of Recurrent Stroke. Dtsch Arztebl Int 2019; 116: 711–717.

   OpenUrl
7. 7.↵
   1. Kleindorfer DO,
   2. Towfighi A,
   3. Chaturvedi S,
   4. Cockroft KM,
   5. Gutierrez J,
   6. Lombardi-Hill D, et al.

   2021 Guideline for the prevention of stroke in patients with stroke and transient ischemic attack; A guideline from the American Heart Association/American Stroke Association. Stroke 20211; 52: e364–e467.
8. 8.↵
   1. Jourdi G,
   2. Godier A,
   3. Lordkipanidzé M,
   4. Marquis-Gravel G,
   5. Gaussem P

   . Antiplatelet Therapy for Atherothrombotic Disease in 2022—From Population to Patient-Centered Approaches. Front Cardiovasc Med 2022; 9: 1–19.

   OpenUrl
9. 9.
   1. Del Giovane C,
   2. Boncoraglio GB,
   3. Bertù L,
   4. Banzi R,
   5. Tramacere I

   . Antiplatelet drugs for secondary prevention in patients with ischemic stroke or transient ischemic attack: a systematic review and network meta-analysis. BMC Neurol 2021; 21: 1–10.

   OpenUrl
10. 10.↵
    1. Minhas JS,
    2. Chithiramohan T,
    3. Wang X,
    4. Barnes SC,
    5. Clough RH,
    6. Kadicheeni M, et al.

    Oral antiplatelet therapy for acute ischaemic stroke (Review). Cochrane Database Syst Rev 2022; 1: 1–16.

    OpenUrl
11. 11.↵
    1. Pace WD,
    2. Earl A,
    3. Bryant C

    . Antiplatelet Therapy for Secondary Prevention of Ischemic Stroke. Cardiovascular 2020; 45: HS8–HS12.

    OpenUrl
12. 12.↵
    1. Dong J,
    2. Wang F,
    3. Sundararajan S

    . Use of Dual Antiplatelet Therapy following Ischemic Stroke. Stroke 2020; 51: e78–e80.

    OpenUrlPubMed
13. 13.↵
    1. Brown DL,
    2. Levine DA,
    3. Albright K,
    4. Kapral MK,
    5. Leung LY,
    6. Reeves MJ, et al.

    Benefits and Risks of Dual Versus Single Antiplatelet Therapy for Secondary Stroke Prevention. Stroke 2021; 52: e468–e479.

    OpenUrlPubMed
14. 14.↵
    1. Wang Y,
    2. Johnston C,
    3. Bath PM,
    4. Meng X,
    5. Jing J,
    6. Xie X, et al.

    Clopidogrel with aspirin in High-risk patients with Acute Non-disabling Cerebrovascular Events II (CHANCE-2): Rationale and design of a multicentre randomised trial. Stroke Vasc Neurol 2021; 6: 280–285.

    OpenUrlAbstract/FREE Full Text
15. 15.↵
    1. Powers WJ,
    2. Rabinstein AA,
    3. Ackerson T,
    4. Adeoye OM,
    5. Bambakidis NC,
    6. Becker K, et al.

    Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2019; 50: e344–e418.

    OpenUrlCrossRefPubMed
16. 16.↵
    1. Pessoa RLC,
    2. Antunes-foschini R,
    3. Rocha EM

    . Survival analysis (Kaplan-Meier curves): a method to predict the future. Arq Bras Oftalmol 2020; 83: 33–35.

    OpenUrl
17. 17.↵
    1. Deo SV

    . Survival analysis — part 2 : Cox proportional hazards model. Indian J Thorac Cardiovasc Surg 2021; 37: 229–233.

    OpenUrl
18. 18.↵
    1. Lee HL,
    2. Kim JT,
    3. Lee JS,
    4. Park MS,
    5. Choi KH,
    6. Cho KH, et al.

    Comparative Effectiveness of Dual Antiplatelet Therapy With Aspirin and Clopidogrel Versus Aspirin Monotherapy in Mild-to-Moderate Acute Ischemic Stroke According to the Risk of Recurrent Stroke: An Analysis of 15 000 Patients From a Nationwide, Multicent. Circ Cardiovasc Qual Outcomes 2020; 13: e006474.

    OpenUrl
19. 19.↵
    1. Hackam DG,
    2. Spence JD

    . Antiplatelet therapy in ischemic stroke and transient ischemic attack: An overview of major trials and meta-analyses. Stroke 2019; 50: 773–778.

    OpenUrlPubMed